Cabigas, Mario P.

HRN: 27-53-14  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/23/2025
07/30/2025
IV
2.25
Q6
TB Bronchiectasis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines